BioNTech SE, a pharmaceutical company based in Germany, specializes in developing cancer therapeutics and vaccines for infectious diseases, including COVID. With a focus on individualized immunotherapy, the company's oncology pipeline offers a range of mRNA-based drugs, cell therapies, bispecific antibodies, and antibody-drug conjugates. Partnered with industry giants like Roche, Pfizer, and Sanofi, BioNTech's ESG score is 24.1, categorizing it as a medium-risk investment. Notably, their COVID vaccine Comirnaty is the company's first commercialized product.